Intervention Review

Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization

  1. Joseph T Thomas1,*,
  2. Peter Muller2,
  3. Christopher S Wilkinson2

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 18 APR 2007

Assessed as up-to-date: 23 JUN 2009

DOI: 10.1002/14651858.CD005541.pub2


How to Cite

Thomas JT, Muller P, Wilkinson CS. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD005541. DOI: 10.1002/14651858.CD005541.pub2.

Author Information

  1. 1

    Mater Health Services, Maternal Fetal Medicine and Obstetrics, South Brisbane, Queensland, Australia

  2. 2

    Women's and Children's Hospital, Department of Perinatal Medicine, Adelaide, Australia

*Joseph T Thomas, Maternal Fetal Medicine and Obstetrics, Mater Health Services, Aubigny Place, Raymond Terrace, South Brisbane, Queensland, 4101, Australia. joseph.thomas@mater.org.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.